Donanemab
-
{
- All
- News
'Donanemab' - 2 News Result(s)
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Groundbreaking New Alzheimer's Drug Slows Progression Of The Disease, Finds Study
The medication had a successful clinical trial and is expected to be approved by the Food and Drug Administration this fall.
'Donanemab' - 2 News Result(s)
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Groundbreaking New Alzheimer's Drug Slows Progression Of The Disease, Finds Study
The medication had a successful clinical trial and is expected to be approved by the Food and Drug Administration this fall.
